Atossa Therapeutics, Inc.

Atossa Therapeutics, Inc.verified

ATOS

Price:

$5.01

Market Cap:

$43.14M

Atossa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is based in Seattle, Washington.

Industry

Biotechnology

IPO Date

2012-11-08

Stock Exchange

NASDAQ

Ticker

ATOS

The Current Ratio as of March 2026 (TTM) for Atossa Therapeutics, Inc. (ATOS) is 6.77

According to Atossa Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.77. This represents a change of -37.89% compared to the average of 10.90 of the last 4 quarters.

Atossa Therapeutics, Inc. (ATOS) Historical Current Ratio (quarterly & annually)

How has ATOS Current Ratio performed in the past?

The mean historical Current Ratio of Atossa Therapeutics, Inc. over the last ten years is 12.78. The current 6.77 Current Ratio has changed 5.20% with respect to the historical average. Over the past ten years (40 quarters), ATOS's Current Ratio was at its highest in in the March 2021 quarter at 102.26. The Current Ratio was at its lowest in in the June 2016 quarter at 1.66.

Quarterly (TTM)
Annual

Average

12.78

Median

8.64

Minimum

1.72

Maximum

45.18

Atossa Therapeutics, Inc. (ATOS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Atossa Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.56%

Maximum Annual Current Ratio = 45.18

Minimum Annual Increase = -74.79%

Minimum Annual Current Ratio = 1.72

Quarterly (TTM)
Annual
YearCurrent RatioChange
202414.99-14.89%
202317.61-17.03%
202221.23-53.02%
202145.181.56%
20202.73-74.79%
201910.83173.27%
20183.96-38.54%
20176.45107.40%
20163.1181.01%
20151.72-57.23%

Atossa Therapeutics, Inc. (ATOS) Average Current Ratio

How has ATOS Current Ratio performed in the past?

The current Current Ratio of Atossa Therapeutics, Inc. (ATOS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

17.94

5-year avg

20.35

10-year avg

12.78

Atossa Therapeutics, Inc. (ATOS) Current Ratio vs. Peers

How is ATOS’s Current Ratio compared to its peers?

Atossa Therapeutics, Inc.’s Current Ratio is greater than Oncolytics Biotech Inc. (1.84), greater than Tevogen Bio Holdings Inc. (0.31), greater than Greenwich LifeSciences, Inc. (2.35), less than Instil Bio, Inc. (34.45), greater than Immix Biopharma, Inc. (1.53), less than Whitehawk Therapeutics Inc (10.26), greater than Clene Inc. (0.83), less than Surrozen, Inc. (13.15), greater than Cognition Therapeutics, Inc. (6.44), less than Coya Therapeutics, Inc. (8.73),

Build a custom stock screener for Atossa Therapeutics, Inc. (ATOS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Atossa Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Atossa Therapeutics, Inc. (ATOS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Atossa Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Atossa Therapeutics, Inc.'s Current Ratio?

How is the Current Ratio calculated for Atossa Therapeutics, Inc. (ATOS)?

What is the highest Current Ratio for Atossa Therapeutics, Inc. (ATOS)?

What is the 3-year average Current Ratio for Atossa Therapeutics, Inc. (ATOS)?

What is the 5-year average Current Ratio for Atossa Therapeutics, Inc. (ATOS)?

How does the current Current Ratio for Atossa Therapeutics, Inc. (ATOS) compare to its historical average?